133 related articles for article (PubMed ID: 12204810)
1. Predictive value of preprocedural fibrinogen concerning coronary stenting.
Otsuka M; Hayashi Y; Ueda H; Imazu M; Kohno N
Atherosclerosis; 2002 Oct; 164(2):371-8. PubMed ID: 12204810
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
[TBL] [Abstract][Full Text] [Related]
3. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
4. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
[TBL] [Abstract][Full Text] [Related]
5. -455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement.
Monraats PS; Rana JS; Zwinderman AH; de Maat MP; Kastelein JP; Agema WR; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Thromb Haemost; 2005 Mar; 93(3):564-9. PubMed ID: 15735811
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
7. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.
Walter DH; Fichtlscherer S; Sellwig M; Auch-Schwelk W; Schächinger V; Zeiher AM
J Am Coll Cardiol; 2001 Mar; 37(3):839-46. PubMed ID: 11693760
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Serruys PW; Foley DP; Suttorp MJ; Rensing BJ; Suryapranata H; Materne P; van den Bos A; Benit E; Anzuini A; Rutsch W; Legrand V; Dawkins K; Cobaugh M; Bressers M; Backx B; Wijns W; Colombo A
J Am Coll Cardiol; 2002 Feb; 39(3):393-9. PubMed ID: 11823075
[TBL] [Abstract][Full Text] [Related]
9. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
12. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis.
Palmerini T; Marzocchi A; Marrozzini C; Ortolani P; Saia F; Bacchi-Reggiani L; Virzì S; Gianstefani S; Branzi A
Circulation; 2005 Oct; 112(15):2332-8. PubMed ID: 16203907
[TBL] [Abstract][Full Text] [Related]
13. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
[TBL] [Abstract][Full Text] [Related]
14. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients.
van der Hoeven BL; Pires NM; Warda HM; Putter H; Quax PH; Schalij MJ; Jukema JW
Int J Cardiol; 2008 Feb; 124(2):166-71. PubMed ID: 17408773
[TBL] [Abstract][Full Text] [Related]
16. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
[TBL] [Abstract][Full Text] [Related]
17. Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting.
Fischell TA; Maheshwari A; Mirza RA; Haller S; Carter AJ; Popma JJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):460-7. PubMed ID: 15789391
[TBL] [Abstract][Full Text] [Related]
18. Culprit coronary lesions requiring percutaneous coronary intervention after vascular surgery often arise from in-stent restenosis of bare metal stents.
Garcia S; Murray ST; Moritz TE; Pierpont G; Goldman S; Larsen GC; Littooy F; Ward HB; McFalls EO
Ann Vasc Surg; 2010 Jul; 24(5):596-601. PubMed ID: 20579583
[TBL] [Abstract][Full Text] [Related]
19. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients.
Van Belle E; Périé M; Braune D; Chmaït A; Meurice T; Abolmaali K; McFadden EP; Bauters C; Lablanche JM; Bertrand ME
J Am Coll Cardiol; 2002 Aug; 40(3):410-7. PubMed ID: 12142104
[TBL] [Abstract][Full Text] [Related]
20. Effect of a short antibiotic treatment with roxithromycin on circulating adhesion molecules after coronary stenting: a single-center pilot trial.
Vandoni P; Morelli B; Lazzati L; Citterio R; Poli A; Fetiveau R; D'Urbano M; Cafiero F; Viganò E; De Servi S
Ital Heart J; 2004 Sep; 5(9):667-72. PubMed ID: 15568594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
